Table 3.
Patient’s characteristics and surgical procedures before and after ERP implementation
| Before ERP(n = 100) | After ERP(n = 100) | p-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (+/− SD) | 59,01 (+/− 12,35) | 59,37 (+/− 13,13) | NS |
| Median (Min/Max) | 60 (16 / 87) | 60 (27 / 91) | |
| ASA score: | |||
| ASA 1 (%) | 21 | 24 | NS |
| ASA 2 (%) | 69 | 65 | |
| ASA 3 (%) | 10 | 11 | |
| BMI (kg/m2) | |||
| Mean (+/− SD) | 24,2 (+/− 4,98) | 27,3 (+/− 7,89) | 0.001 |
| Median (Min/Max) | 23 (16 / 41) | 25 (18 / 63) | |
| Oncological indications (%) | |||
| Endometrial cancer* | 22 | 42 | 0.003* |
| Cervical cancer | 42 | 39 | |
| Ovarian cancer | 22 | 14 | |
| Other (Border line ovarian tumor, endometrial hyperplasia, CIN) | 14 | 5 | |
| Surgical approaches | |||
| Conventional lap / Robotic assisted lap | 88 | 87 | NS |
| Open | 12 | 13 | |
| Conversion to open | 2 | 2 | |
| Surgical procedures | NS | ||
| Total Hysterectomy** | 43 | 48 | |
| Total Hysterectomy** with pelvic lymphadenectomy | 11 | 16 | NS |
| Total Hysterectomy** with pelvic and aortic lymphadenectomy | 9 | 9 | |
| Isolated Lymphadenectomy: | 37 | 27 | |
| Pelvic lymphadenectomy | 12 | 4 | |
| Para-aortic lymphadenectomy | 21 | 18 | |
| Both | 4 | 5 | |
Abbreviations: BMI body mass index, SD standard deviation, CIN Cervical Intraepithelial Neoplasia
*significative difference in oncological indications in relation with the rate of endometrial cancer, higher in the group after ERP
**total hysterectomy was always associated with bilateral oophorectomy